Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020     67,832,706 (13,739,171)            
Balance, at period start at Dec. 31, 2020 $ 975,818 $ (79,842) $ 339 $ (110,466) $ 1,166,774 $ (108,470) $ (398) $ (79,912) $ 28,628 $ (519)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     27,043              
Exercise of stock options 522   $ 0   522          
Issuance of common stock - vesting of restricted stock units (in shares)     455,349              
Issuance of common stock - vesting of restricted stock units 2   $ 2              
Stock-based compensation expense 14,013       14,013          
Shares withheld to satisfy tax withholdings (in shares)       (147,041)            
Shares withheld to satisfy tax withholdings (9,541)     $ (9,541)            
Share repurchase (in shares)       (24,227)            
Share repurchase (1,672)     $ (1,672)            
Foreign currency translation loss, net of taxes (624)           (624)      
Other 118                 118
Net income (loss) 14,935             14,946   (11)
Ending balance (in shares) at Mar. 31, 2021     68,315,098 (13,910,439)            
Balance, at period end at Mar. 31, 2021 $ 913,729   $ 341 $ (121,679) 1,072,839   (1,022) (36,338)   (412)
Beginning balance (in shares) at Dec. 31, 2021 68,879,152   68,879,152 (14,086,064)            
Balance, at period start at Dec. 31, 2021 $ 959,542   $ 344 $ (134,996) 1,131,628   (1,899) (37,988)   2,453
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares) 38,681   38,681              
Exercise of stock options $ 658       658          
Issuance of common stock - vesting of restricted stock units (in shares)     514,319              
Issuance of common stock - vesting of restricted stock units 3   $ 3              
Stock-based compensation expense 21,690       21,690          
Shares withheld to satisfy tax withholdings (in shares)       (170,992)            
Shares withheld to satisfy tax withholdings (12,570)     $ (12,570)            
Foreign currency translation loss, net of taxes (1,478)           (1,478)      
Other 18       (84)         102
Net income (loss) $ (14,708)             (13,859)   (849)
Ending balance (in shares) at Mar. 31, 2022 69,432,152   69,432,152 (14,257,056)            
Balance, at period end at Mar. 31, 2022 $ 953,155   $ 347 $ (147,566) $ 1,153,892   $ (3,377) $ (51,847)   $ 1,706